Rarecyte, Inc.

Rarecyte, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Leaders across Research, Translational Medicine and the Clinic rely on RareCyte as a one-stop resource for Spatial Biology and Liquid Biopsy solutions. Headquartered in Seattle, WA, RareCyte is an innovative precision biology company that has developed technologies and end-to-end integrated platforms enabling advances in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy. Our highly multiplexed fluorescent imaging systems, reagents and contract services empower investigators to unlock spatial context for key biomarkers and develop therapeutics and companion diagnostics through rare cell analysis.
Looking for a particular Rarecyte, Inc. employee's phone or email?

Rarecyte, Inc. Questions

News

From spatial transcriptomics to spatial protein profiling - Drug Discovery News

From spatial transcriptomics to spatial protein profiling Drug Discovery News

Could cannabis-based drugs finally offer an alternative to opioids? - Drug Discovery News

Could cannabis-based drugs finally offer an alternative to opioids? Drug Discovery News

RareCyte® Inc. reports significant 2021 growth of Precision Biology™ Services business and customer uptake of Orion™ Spatial Biology instruments and reagents - PR Newswire

RareCyte® Inc. reports significant 2021 growth of Precision Biology™ Services business and customer uptake of Orion™ Spatial Biology instruments and reagents PR Newswire

Beyond Circulating Tumor Cell Enumeration: Cell-Based Liquid Biopsy to Assess Protein Biomarkers and Cancer Genomics Using the RareCyte® Platform - Frontiers

Beyond Circulating Tumor Cell Enumeration: Cell-Based Liquid Biopsy to Assess Protein Biomarkers and Cancer Genomics Using the RareCyte® Platform Frontiers

Seattle-based RareCyte raises $20M for cell analysis products - GeekWire

Seattle-based RareCyte raises $20M for cell analysis products GeekWire

BioMed X and Novo Nordisk launch new collaboration in oral peptide drug delivery - Drug Discovery News

BioMed X and Novo Nordisk launch new collaboration in oral peptide drug delivery Drug Discovery News

RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform and Expand Global Commercial Channels - PR Newswire

RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform and Expand Global Commercial Channels PR Newswire

Seattle startup RareCyte raises $24M to advance new high-speed cell imaging platform - GeekWire

Seattle startup RareCyte raises $24M to advance new high-speed cell imaging platform GeekWire

Navigate BioPharma Services, Inc. announces collaboration with RareCyte, Inc. to provide enhanced spatial biology capabilities using the Orion™ Platform - PR Newswire

Navigate BioPharma Services, Inc. announces collaboration with RareCyte, Inc. to provide enhanced spatial biology capabilities using the Orion™ Platform PR Newswire

Weekly Rundown: Scientists told to remove mRNA tech from grants - Drug Discovery News

Weekly Rundown: Scientists told to remove mRNA tech from grants Drug Discovery News

LBAI Orion imaging featured in RareCyte 2026 calendar - Université de Bretagne Occidentale (UBO, Brest)

LBAI Orion imaging featured in RareCyte 2026 calendar Université de Bretagne Occidentale (UBO, Brest)

RareCyte Closes $22M Financing for Global Commercialization and Platform Expansion into Tissue Multiplexing - PR Newswire

RareCyte Closes $22M Financing for Global Commercialization and Platform Expansion into Tissue Multiplexing PR Newswire

Knocking down the walls that make pancreatic tumors unreachable - Drug Discovery News

Knocking down the walls that make pancreatic tumors unreachable Drug Discovery News

Reducing the risk of bacteremia - Drug Discovery News

Reducing the risk of bacteremia Drug Discovery News

Making cancer treatment easier to swallow - Drug Discovery News

Making cancer treatment easier to swallow Drug Discovery News

How to grow an ear and why - Drug Discovery News

How to grow an ear and why Drug Discovery News

Pfizer's next-generation therapies for inflammatory bowel disease - Drug Discovery News

Pfizer's next-generation therapies for inflammatory bowel disease Drug Discovery News

One small molecule may transform osteoporosis treatment - Drug Discovery News

One small molecule may transform osteoporosis treatment Drug Discovery News

Ivermectin is a wonder drug, but not a cure-all - Drug Discovery News

Ivermectin is a wonder drug, but not a cure-all Drug Discovery News

Novartis subsidiary Sandoz launches Zarxio - Drug Discovery News

Novartis subsidiary Sandoz launches Zarxio Drug Discovery News

Top Rarecyte, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant